Minimum age of 11 set for UK puberty blocker trial
24 hours ago Alison Holt Social affairs editor Getty Images Gender-questioning children will have to be at least 11 years old to take part in a clinical trial assessing the risks and benefits of puberty-blocking drugs. The planned Pathways Trial was paused in February 2026 after the Medicines and HealthcareContinue Reading












